{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:30:06Z","timestamp":1791559806682,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    RIPK1 is a death-domain (DD) containing kinase involved in regulating apoptosis, necroptosis and inflammation. RIPK1 activation is known to be regulated by its DD-mediated interaction and ubiquitination, though underlying mechanisms remain incompletely understood. Here we show that K627 in human RIPK1-DD and its equivalent K612 in murine RIPK1-DD is a key ubiquitination site that regulates the overall ubiquitination pattern of RIPK1 and its DD-mediated interactions with other DD-containing proteins. K627R\/K612R mutation inhibits the activation of RIPK1 and blocks both apoptosis and necroptosis mediated by TNFR1 signaling. However,\n                    <jats:italic>Ripk1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>K612R\/K612R<\/jats:italic>\n                    <\/jats:sup>\n                    mutation sensitizes cells to necroptosis and caspase-1 activation in response to TLRs signaling.\n                    <jats:italic>Ripk1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>K612R\/K612R<\/jats:italic>\n                    <\/jats:sup>\n                    mice are viable, but develop age-dependent reduction of RIPK1 expression, spontaneous intestinal inflammation and splenomegaly, which can be rescued by antibiotic treatment and partially by\n                    <jats:italic>Ripk3<\/jats:italic>\n                    deficiency. Furthermore, we show that the interaction of RIPK1 with FADD contributes to suppressing the activation of RIPK3 mediated by TLRs signaling. Our study demonstrates the distinct roles of K612 ubiquitination in mRIPK1\/K627 ubiquitination in hRIPK1 in regulating its pro-death kinase activity in response to TNF\u03b1 and pro-survival activity in response to TLRs signaling.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-19935-y","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T06:20:56Z","timestamp":1607667656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners"],"prefix":"10.1038","volume":"11","author":[{"given":"Xingyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heling","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"19935_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0071-y","author":"L Mifflin","year":"2020","unstructured":"Mifflin, L., Ofengeim, D. & Yuan, J. Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/s41573-020-0071-y (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"19935_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan, J., Amin, P. & Ofengeim, D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat. Rev. Neurosci. 20, 19\u201333 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"19935_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1126\/science.aar2641","volume":"361","author":"D Cuchet-Lourenco","year":"2018","unstructured":"Cuchet-Lourenco, D. et al. Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science 361, 810\u2013813 (2018).","journal-title":"Science"},{"key":"19935_CR4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1073\/pnas.1813582116","volume":"116","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases. Proc. Natl Acad. Sci. USA 116, 970\u2013975 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19935_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ajg.2013.403","volume":"109","author":"M Pierdomenico","year":"2014","unstructured":"Pierdomenico, M. et al. Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation. Am. J. Gastroenterol. 109, 279\u2013287 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"19935_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2014.04.018","volume":"157","author":"CP Dillon","year":"2014","unstructured":"Dillon, C. P. et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189\u20131202 (2014).","journal-title":"Cell"},{"key":"19935_CR7","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard, J. A. et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175\u20131188 (2014).","journal-title":"Cell"},{"key":"19935_CR8","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1073\/pnas.1401857111","volume":"111","author":"WJ Kaiser","year":"2014","unstructured":"Kaiser, W. J. et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc. Natl Acad. Sci. USA 111, 7753\u20137758 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19935_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80252-6","volume":"4","author":"H Hsu","year":"1996","unstructured":"Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387\u2013396 (1996).","journal-title":"Immunity"},{"key":"19935_CR10","doi-asserted-by":"publisher","first-page":"E2001","DOI":"10.1073\/pnas.1722013115","volume":"115","author":"H Meng","year":"2018","unstructured":"Meng, H. et al. Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis. Proc. Natl Acad. Sci. USA 115, E2001\u2013E2009 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19935_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181\u2013190 (2003).","journal-title":"Cell"},{"key":"19935_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tcb.2016.01.006","volume":"26","author":"N Peltzer","year":"2016","unstructured":"Peltzer, N., Darding, M. & Walczak, H. Holding RIPK1 on the ubiquitin leash in TNFR1 signaling. Trends Cell Biol. 26, 445\u2013461 (2016).","journal-title":"Trends Cell Biol."},{"key":"19935_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","volume":"30","author":"MJ Bertrand","year":"2008","unstructured":"Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689\u2013700 (2008).","journal-title":"Mol. Cell"},{"key":"19935_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ncb1821","volume":"11","author":"F Tokunaga","year":"2009","unstructured":"Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat. Cell Biol. 11, 123\u2013132 (2009).","journal-title":"Nat. Cell Biol."},{"key":"19935_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.molcel.2009.10.013","volume":"36","author":"TL Haas","year":"2009","unstructured":"Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831\u2013844 (2009).","journal-title":"Mol. Cell"},{"key":"19935_CR16","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.celrep.2015.11.009","volume":"13","author":"P Draber","year":"2015","unstructured":"Draber, P. et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 13, 2258\u20132272 (2015).","journal-title":"Cell Rep."},{"key":"19935_CR17","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.celrep.2016.07.086","volume":"16","author":"S Kupka","year":"2016","unstructured":"Kupka, S. et al. SPATA2-mediated binding of CYLD to HOIP enables CYLD recruitment to signaling complexes. Cell Rep. 16, 2271\u20132280 (2016).","journal-title":"Cell Rep."},{"key":"19935_CR18","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.15252\/embr.201642592","volume":"17","author":"L Schlicher","year":"2016","unstructured":"Schlicher, L. et al. SPATA2 promotes CYLD activity and regulates TNF-induced NF-kappaB signaling and cell death. EMBO Rep. 17, 1485\u20131497 (2016).","journal-title":"EMBO Rep."},{"key":"19935_CR19","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1101\/gad.299776.117","volume":"31","author":"R Wei","year":"2017","unstructured":"Wei, R. et al. SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination. Genes Dev. 31, 1162\u20131176 (2017).","journal-title":"Genes Dev."},{"key":"19935_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molcel.2015.07.032","volume":"60","author":"Y Dondelinger","year":"2015","unstructured":"Dondelinger, Y. et al. NF-kappaB-independent role of IKKalpha\/IKKbeta in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol. Cell 60, 63\u201376 (2015).","journal-title":"Mol. Cell"},{"key":"19935_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2008.03.036","volume":"133","author":"L Wang","year":"2008","unstructured":"Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133, 693\u2013703 (2008).","journal-title":"Cell"},{"key":"19935_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00406-w","volume":"8","author":"J Geng","year":"2017","unstructured":"Geng, J. et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat. Commun. 8, 359 (2017).","journal-title":"Nat. Commun."},{"key":"19935_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112\u20131123 (2009).","journal-title":"Cell"},{"key":"19935_CR24","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137, 1100\u20131111 (2009).","journal-title":"Cell"},{"key":"19935_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"DW Zhang","year":"2009","unstructured":"Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332\u2013336 (2009).","journal-title":"Science"},{"key":"19935_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213\u2013227 (2012).","journal-title":"Cell"},{"key":"19935_CR27","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1073\/pnas.1200012109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao, J. et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc. Natl Acad. Sci. USA 109, 5322\u20135327 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19935_CR28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821\u2013832 (2010).","journal-title":"Cell"},{"key":"19935_CR29","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4049\/jimmunol.1402167","volume":"194","author":"K Moriwaki","year":"2015","unstructured":"Moriwaki, K., Bertin, J., Gough, P. J. & Chan, F. K. A RIPK3-caspase 8 complex mediates atypical pro-IL-1beta processing. J. Immunol. 194, 1938\u20131944 (2015).","journal-title":"J. Immunol."},{"key":"19935_CR30","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1002\/rcm.3227","volume":"21","author":"S Mollah","year":"2007","unstructured":"Mollah, S. et al. Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins. Rapid Commun. Mass Spectrom. 21, 3357\u20133364 (2007).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"19935_CR31","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1074\/mcp.M112.017905","volume":"11","author":"SA Wagner","year":"2012","unstructured":"Wagner, S. A. et al. Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol. Cell Proteom. 11, 1578\u20131585 (2012).","journal-title":"Mol. Cell Proteom."},{"key":"19935_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","volume":"44","author":"W Kim","year":"2011","unstructured":"Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325\u2013340 (2011).","journal-title":"Mol. Cell"},{"key":"19935_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.molcel.2006.03.026","volume":"22","author":"CK Ea","year":"2006","unstructured":"Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. & Chen, Z. J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245\u2013257 (2006).","journal-title":"Mol. Cell"},{"key":"19935_CR34","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","volume":"10","author":"D Ofengeim","year":"2015","unstructured":"Ofengeim, D. et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 10, 1836\u20131849 (2015).","journal-title":"Cell Rep."},{"key":"19935_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1310050","volume":"370","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A. & Green, D. R. Necroptosis. N. Engl. J. Med. 370, 455\u2013465 (2014).","journal-title":"N. Engl. J. Med."},{"key":"19935_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1101\/gad.312561.118","volume":"32","author":"B Shan","year":"2018","unstructured":"Shan, B., Pan, H., Najafov, A. & Yuan, J. Necroptosis in development and diseases. Genes Dev. 32, 327\u2013340 (2018).","journal-title":"Genes Dev."},{"key":"19935_CR37","doi-asserted-by":"publisher","first-page":"871","DOI":"10.4161\/cc.11.5.19300","volume":"11","author":"YL Pobezinskaya","year":"2012","unstructured":"Pobezinskaya, Y. L. & Liu, Z. The role of TRADD in death receptor signaling. Cell Cycle 11, 871\u2013876 (2012).","journal-title":"Cell Cycle"},{"key":"19935_CR38","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1128\/MCB.26.9.3505-3513.2006","volume":"26","author":"L Zheng","year":"2006","unstructured":"Zheng, L. et al. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol. Cell Biol. 26, 3505\u20133513 (2006).","journal-title":"Mol. Cell Biol."},{"key":"19935_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature13706","volume":"513","author":"N Takahashi","year":"2014","unstructured":"Takahashi, N. et al. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature 513, 95\u201399 (2014).","journal-title":"Nature"},{"key":"19935_CR40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature10273","volume":"477","author":"PS Welz","year":"2011","unstructured":"Welz, P. S. et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330\u2013334 (2011).","journal-title":"Nature"},{"key":"19935_CR41","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1016\/j.celrep.2016.06.103","volume":"16","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. MLKL and FADD are critical for suppressing progressive lymphoproliferative disease and activating the NLRP3 inflammasome. Cell Rep. 16, 3247\u20133259 (2016).","journal-title":"Cell Rep."},{"key":"19935_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.immuni.2016.07.016","volume":"45","author":"S Alvarez-Diaz","year":"2016","unstructured":"Alvarez-Diaz, S. et al. The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis. Immunity 45, 513\u2013526 (2016).","journal-title":"Immunity"},{"key":"19935_CR43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/08916934.2017.1283405","volume":"50","author":"E Kontaki","year":"2017","unstructured":"Kontaki, E. et al. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses. Autoimmunity 50, 170\u2013181 (2017).","journal-title":"Autoimmunity"},{"key":"19935_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0394632017711055","volume":"30","author":"N Ma","year":"2017","unstructured":"Ma, N., Liu, Q., Hou, L., Wang, Y. & Liu, Z. MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer. Int. J. Immunopathol. Pharm. 30, 152\u2013162 (2017).","journal-title":"Int. J. Immunopathol. Pharm."},{"key":"19935_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fcimb.2014.00028","volume":"4","author":"KK Gkouskou","year":"2014","unstructured":"Gkouskou, K. K., Deligianni, C., Tsatsanis, C. & Eliopoulos, A. G. The gut microbiota in mouse models of inflammatory bowel disease. Front. Cell Infect. Microbiol. 4, 28 (2014).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"19935_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10238-013-0270-5","volume":"15","author":"A Hakansson","year":"2015","unstructured":"Hakansson, A. et al. Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin. Exp. Med. 15, 107\u2013120 (2015).","journal-title":"Clin. Exp. Med."},{"key":"19935_CR47","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser, W. J. et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288, 31268\u201331279 (2013).","journal-title":"J. Biol. Chem."},{"key":"19935_CR48","doi-asserted-by":"publisher","first-page":"20054","DOI":"10.1073\/pnas.1116302108","volume":"108","author":"S He","year":"2011","unstructured":"He, S., Liang, Y., Shao, F. & Wang, X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl Acad. Sci. USA 108, 20054\u201320059 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19935_CR49","doi-asserted-by":"publisher","first-page":"E3206","DOI":"10.1073\/pnas.1407068111","volume":"111","author":"S McComb","year":"2014","unstructured":"McComb, S. et al. Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. Proc. Natl Acad. Sci. USA 111, E3206\u2013E3213 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19935_CR50","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4049\/jimmunol.159.3.1451","volume":"159","author":"D Ferrari","year":"1997","unstructured":"Ferrari, D. et al. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159, 1451\u20131458 (1997).","journal-title":"J. Immunol."},{"key":"19935_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2017.00123","volume":"8","author":"AL Giuliani","year":"2017","unstructured":"Giuliani, A. L., Sarti, A. C., Falzoni, S. & Di Virgilio, F. The P2X7 receptor-interleukin-1 liaison. Front. Pharm. 8, 123 (2017).","journal-title":"Front. Pharm."},{"key":"19935_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev.immunol.25.022106.141656","volume":"25","author":"HH Park","year":"2007","unstructured":"Park, H. H. et al. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 25, 561\u2013586 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"19935_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature10400","volume":"477","author":"C G\u00fcnther","year":"2011","unstructured":"G\u00fcnther, C. et al. Caspase-8 regulates TNF-\u03b1-induced epithelial necroptosis and terminal ileitis. Nature 477, 335\u2013339 (2011).","journal-title":"Nature"},{"key":"19935_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.immuni.2016.02.020","volume":"44","author":"K Vlantis","year":"2016","unstructured":"Vlantis, K. et al. NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-kappaB-dependent and -independent functions. Immunity 44, 553\u2013567 (2016).","journal-title":"Immunity"},{"key":"19935_CR55","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature09852","volume":"471","author":"A Oberst","year":"2011","unstructured":"Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363\u2013367 (2011).","journal-title":"Nature"},{"key":"19935_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41556-017-0003-1","volume":"20","author":"SA Dziedzic","year":"2018","unstructured":"Dziedzic, S. A. et al. ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC. Nat. Cell Biol. 20, 58\u201368 (2018).","journal-title":"Nat. Cell Biol."},{"key":"19935_CR57","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/cdd.2014.76","volume":"21","author":"S Orozco","year":"2014","unstructured":"Orozco, S. et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ. 21, 1511\u20131521 (2014).","journal-title":"Cell Death Differ."},{"key":"19935_CR58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nature20559","volume":"540","author":"K Newton","year":"2016","unstructured":"Newton, K. et al. RIPK1 inhibits ZBP1-driven necroptosis during development. Nature 540, 129\u2013133 (2016).","journal-title":"Nature"},{"key":"19935_CR59","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.4049\/jimmunol.1900216","volume":"203","author":"JP Ingram","year":"2019","unstructured":"Ingram, J. P. et al. ZBP1\/DAI drives RIPK3-mediated cell death induced by IFNs in the absence of RIPK1. J. Immunol. 203, 1348\u20131355 (2019).","journal-title":"J. Immunol."},{"key":"19935_CR60","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19935-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:28:57Z","timestamp":1697318937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19935"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19935-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,11]]},"assertion":[{"value":"23 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J. Yuan is a consultant for Denali Therapeutics and Sanofi. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6364"}}